Logo image of LI.CA

AMERICAN LITHIUM CORP (LI.CA) Stock Fundamental Analysis

TSX-V:LI - TSX Venture Exchange - CA0272592092 - Common Stock - Currency: CAD

0.34  -0.01 (-2.86%)

Fundamental Rating

2

LI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 805 industry peers in the Metals & Mining industry. LI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year LI has reported negative net income.
LI had a negative operating cash flow in the past year.
LI had negative earnings in each of the past 5 years.
In the past 5 years LI always reported negative operating cash flow.
LI.CA Yearly Net Income VS EBIT VS OCF VS FCFLI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

LI has a Return On Assets (-15.02%) which is comparable to the rest of the industry.
LI has a Return On Equity (-15.28%) which is in line with its industry peers.
Industry RankSector Rank
ROA -15.02%
ROE -15.28%
ROIC N/A
ROA(3y)-17.84%
ROA(5y)-176.29%
ROE(3y)-18.15%
ROE(5y)-275.43%
ROIC(3y)N/A
ROIC(5y)N/A
LI.CA Yearly ROA, ROE, ROICLI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

LI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LI.CA Yearly Profit, Operating, Gross MarginsLI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, LI has more shares outstanding
Compared to 5 years ago, LI has more shares outstanding
LI has a better debt/assets ratio than last year.
LI.CA Yearly Shares OutstandingLI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
LI.CA Yearly Total Debt VS Total AssetsLI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

LI has an Altman-Z score of 14.68. This indicates that LI is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 14.68, LI is doing good in the industry, outperforming 78.14% of the companies in the same industry.
LI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.00, LI perfoms like the industry average, outperforming 58.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14.68
ROIC/WACCN/A
WACCN/A
LI.CA Yearly LT Debt VS Equity VS FCFLI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

LI has a Current Ratio of 3.15. This indicates that LI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of LI (3.15) is better than 63.69% of its industry peers.
A Quick Ratio of 3.15 indicates that LI has no problem at all paying its short term obligations.
LI has a better Quick ratio (3.15) than 65.20% of its industry peers.
Industry RankSector Rank
Current Ratio 3.15
Quick Ratio 3.15
LI.CA Yearly Current Assets VS Current LiabilitesLI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.57% over the past year.
EPS 1Y (TTM)44.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.53%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, LI will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.24% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y46.32%
EPS Next 2Y25.32%
EPS Next 3Y16.24%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LI.CA Yearly EPS VS EstimatesLI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LI. In the last year negative earnings were reported.
Also next year LI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LI.CA Price Earnings VS Forward Price EarningsLI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LI.CA Per share dataLI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

LI's earnings are expected to grow with 16.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.32%
EPS Next 3Y16.24%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN LITHIUM CORP

TSX-V:LI (5/30/2025, 7:00:00 PM)

0.34

-0.01 (-2.86%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-28 2025-05-28/amc
Earnings (Next)N/A N/A
Inst Owners0.27%
Inst Owner ChangeN/A
Ins Owners4.69%
Ins Owner ChangeN/A
Market Cap74.95M
Analysts43.33
Price Target0.61 (79.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-14.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.47
P/tB 0.47
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS0.72
TBVpS0.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.02%
ROE -15.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-17.84%
ROA(5y)-176.29%
ROE(3y)-18.15%
ROE(5y)-275.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 81.14%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.15
Quick Ratio 3.15
Altman-Z 14.68
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2060.61%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.53%
EPS Next Y46.32%
EPS Next 2Y25.32%
EPS Next 3Y16.24%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y47.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.61%
EBIT Next 3Y4.89%
EBIT Next 5YN/A
FCF growth 1Y51.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.25%
OCF growth 3YN/A
OCF growth 5YN/A